IMUX as of Nov 3 · 18:54 ET
IMUXNasdaqPharmaceutical Preparations

Immunic, Inc. · Brief

Next report

9 days

Nov 12 · before openest.Q3 FY26

Expected move

Inputs

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±18.3%▲+9.79%×0.53
quarterimplied−20%0+20%realized×
Q2 FY26±18.3%▲+9.79%×0.53
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2

7disclosed supplier and customer ties in SEC filingsSEC filings
57managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

13managers whose positions together comprise most of the reported value13F · Jun 30 '26
21 of 22largest reporting managers cutting their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IMUX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±31.1% into Nov 12 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.